MaxCyte, Inc. (MXCT) Gross margin 2019–2025
MaxCyte, Inc. (MXCT) gross margin by fiscal year — reported gross profit divided by reported revenue.
127.9%FY2025 · since FY2019: 144.2% → 127.9%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 127.9% | -14.0 pp |
| FY2024 | 141.9% | -45.5 pp |
| FY2023 | 187.4% | +51.2 pp |
| FY2022 | 136.2% | -4.0 pp |
| FY2021 | 140.2% | -11.2 pp |
| FY2020 | 151.5% | +7.2 pp |
| FY2019 | 144.2% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice